Technical Analysis for MXC - MGC Pharmaceuticals Limited

Grade Last Price % Change Price Change
F 3.6005 -3.99% -0.15
MXC closed down 3.99 percent on Friday, April 16, 2021, on 14 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical MXC trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
180 Bullish Setup Bullish Swing Setup -3.99%
Wide Bands Range Expansion -3.99%
Wide Bands Range Expansion 1.14%
Narrow Range Bar Range Contraction -3.99%
NR7 Range Contraction -3.99%
Wide Bands Range Expansion -3.99%
1,2,3 Pullback Bullish Bullish Swing Setup -1.36%
Older End-of-Day Signals for MXC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


MGC Pharmaceuticals Limited Description

MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.


Keywords: Health Clinical Trial Pharmaceutical Industry Clinical Research Health Sciences Pharmaceutical Industry In China Clinical Pharmacology Dementia Design Of Experiments

Is MXC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 9.3
52 Week Low 2.175
Average Volume 49,366,576
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 3.85
10-Day Moving Average 3.73
Average True Range 0.49
ADX 32.66
+DI 26.93
-DI 17.15
Chandelier Exit (Long, 3 ATRs ) 3.35
Chandelier Exit (Short, 3 ATRs ) 4.76
Upper Bollinger Band 4.46
Lower Bollinger Band 3.24
Percent B (%b) 0.3
BandWidth 31.82
MACD Line -0.21
MACD Signal Line -0.24
MACD Histogram 0.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.05
Resistance 3 (R3) 4.07 3.93 3.98
Resistance 2 (R2) 3.93 3.82 3.93 3.95
Resistance 1 (R1) 3.77 3.75 3.70 3.75 3.93
Pivot Point 3.63 3.63 3.60 3.63 3.63
Support 1 (S1) 3.47 3.52 3.40 3.45 3.28
Support 2 (S2) 3.33 3.45 3.33 3.25
Support 3 (S3) 3.17 3.33 3.23
Support 4 (S4) 3.15